It is clear from these findings that while the use of growth factors to treat CNS diseases, such as AD and PD, is a promising strategy, the BBB poses a robust obstacle in turning such strategies into viable treatment options in the clinic
Conclusion The authors concluded that maternal exposure to GLP-1 receptor agonists did not have a significant association with major congenital malformations, stillbirth, spontaneous abortion, small for gestational age, or preterm birth
For glutathione, it is more on the political side, and the systems are not good enough in those countries to know how to use it properly. If glutathione were not that popular and all the clinics and practitioners followed the guidelines within protocol in other countries, would the FDA ban glutathione
However, NLY01, a brain-penetrant, pegylated, longer-lasting version of exenatide, provided no significant benefits in PD patients with a H&Y stage of 2.5 and an average disease duration of 1 year, as assessed by the MDS-UPDRS Parts II and III scores
PBMs and state plans, instead, chose to slam the door
High Fasting Blood Sugar: Fasting blood sugar (glucose) levels equal to or greater than 100 mg/dL
-1775582746855.png&w=3840&q=75)
